p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant Prostate-Reference-Cited by-同舟云学术

p53, c-erbB-2 and the Epidermal Growth Factor Receptor in the Benign and Malignant Prostate

Published:1992-02 Issue:2 Volume:147 Page:496-499
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

Mellon Kilian¹²³,Thompson Steven¹²³,Charlton Richard G.¹²³,Marsh Colin¹²³,Robinson Mary¹²³,Lane David P.¹²³,Harris Adrian L.¹²³,Horne C.H. Wilson¹²³,Neal David E.¹²³

Affiliation:

1. From the Department of Urology and University Department of Surgery and Department of Pathology, Freeman Hospital, Newcastle upon Tyne

2. The University Department of Pathology, University of Newcastle upon Tyne, ICRF Molecular Immunochemistry Laboratory, Potter’s Bar, Herts

3. The Institute of Molecular Medicine, John Radcliffe Hospital, Oxford

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference35 articles.

1. T antigen is bound to a host protein in SV40 transformed cells;Lane;Nature (Lond.),1979

2. p53 and DNA polymerase-a compete for binding to SV40 T antigen;Gannon;Nature (Lond.),1987

3. The p53 oncogene;Jenkins,1988

4. Human p53 gene is localised to short arm of chromosome 17;Miller;Nature (Lond.),1986

5. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas;Baker;Science,1989

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma;Annals of Diagnostic Pathology;2023-12

2. Nonneoplastic Diseases of the Prostate;Urologic Surgical Pathology;2020

3. The Expression Frequency of Androgen Receptor, c-erbB2 and CD117 in Acinar Adenocarcinoma of Prostate and Normal Prostate Tissue and It’s Clinical Importance;Üroonkoloji Bülteni;2015-12-05

4. ErbB receptor tyrosine kinase family expression levels in urothelial bladder carcinoma;Pathology - Research and Practice;2013-02

5. Molecular Markers of Prostate Cancer Outcome;Biomarkers in Oncology;2012-07-22